The biotechnology market experiences significant growth, fueled by advancements in genetic therapies and supportive global ...

Investors interested in Medical - Biomedical and Genetics stocks are likely familiar with Incyte (INCY) and Vertex Pharmaceuticals (VRTX ... of our Style Scores system. The proven Zacks Rank ...

In the latest market close, Vertex Pharmaceuticals (VRTX) reached $409.56 ... these estimate changes and presents a viable rating system. The Zacks Rank system, stretching from #1 (Strong Buy ...

Below is Validea's guru fundamental report for VERTEX PHARMACEUTICALS INC (VRTX). Of the 22 guru strategies we follow, VRTX rates highest using our P/B Growth Investor model based on the published ...

This enables strong operating margins, profitability, it allows us to reinvest in R&D, and this is what perpetuates this virtuous cycle. The key pillars of our differentiated disease-first R&D ...

In a report released today, Joon Lee from Truist Financial maintained a Buy rating on Vertex Pharmaceuticals (VRTX – Research Report). The company’s shares closed last Friday at $409.56.

In a report released today, Mohit Bansal from Wells Fargo assigned a Buy rating to Vertex Pharmaceuticals (VRTX – Research Report), with a price target of $460.00. The company’s shares closed ...